Role of coagulation parameters and inflammatory biomarkers in coronavirus disease 2019 patients: A demystifying endeavor
BACKGROUND: Coronavirus disease 2019 (COVID-19) globally known as COVID-19 is a heterogeneous disease caused by the severe acute respiratory syndrome coronavirus 2. COVID-19 patients having severe disease and are critically ill are more prone to have abnormal coagulation prolife. It may lead to thro...
Main Authors: | B N Kumarguru, Sindhu Sreegiri, D Swathi, A S Ramaswamy, C A Arathi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of Applied Hematology |
Subjects: | |
Online Access: | http://www.jahjournal.org/article.asp?issn=1658-5127;year=2023;volume=14;issue=3;spage=214;epage=224;aulast=Kumarguru |
Similar Items
-
Coronavirus Disease 2019 and Thyroid Diseases
by: CHEN Zihan, et al.
Published: (2022-05-01) -
Understanding the unusual viral outbreak: Coronavirus disease 2019
by: Tarun Kumar Suvvari, et al.
Published: (2020-01-01) -
Case Series of Patients with Coronavirus Disease 2019 Pneumonia Treated with Hydroxychloroquine
by: Tomohiro Tanaka, et al.
Published: (2023-03-01) -
Coronavirus Disease 2019: A Brief Review of the Clinical Manifestations and Pathogenesis to the Novel Management Approaches and Treatments
by: Omid Kooshkaki, et al.
Published: (2020-10-01) -
Correlation of clinical, laboratory, ventilation, and outcome parameters in hospitalized Coronavirus Disease 2019-infected patients with computed tomography severity score
by: Mohammed A Ibrahim, et al.
Published: (2023-01-01)